Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Schizophr Res. 2013 Apr 6;147(1):10.1016/j.schres.2013.02.017. doi: 10.1016/j.schres.2013.02.017

Figure 3.

Figure 3

Mean NF-κBp50 (A), NF-κBp65 (B), cPLA2-IVA (E), sPLA2-IIA (F) and iPLA2-VIA (G), protein levels (with representative immunoblots) in frontal cortex from control (n = 10) and SZ (n = 10) subjects. Bar graphs are ratios of optical densities of NF-κBp50 and NF-κBp65, cPLA2-IVA, sPLA2-IIA and iPLA2-VIA to β-actin, expressed as percent of control. NF-κBp50 (C), NF-κBp65 (D), cPLA2-IVA (H), sPLA2-IIA (I) and iPLA2-VIA (J) mRNA levels in postmortem frontal cortex from the control (n = 10) and SZ (n = 10) subjects, measured using quantitative RT-PCR. Data are levels of cPLA2-IVA, sPLA2-IIA and iPLA2-VIA in SZ normalized to the endogenous control (β-globulin) and relative to the control (calibrator), using the ΔΔCT method. Mean ± SEM. ** p < 0.01, *** p < 0.001.